Rationally Designed Molecules Synergistically Modulate Multifaceted Aβ Toxicity, Microglial Activation, and...

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder.
• Key pathological hallmarks include amyloid-beta (Aβ) aggregation, metal ion dyshomeostasis, oxidative stress, and neuroinflammation.

Purpose of the Study:

• To design and synthesize multifunctional modulators for synergistic treatment of AD.
• To evaluate the efficacy of a novel naphthalene monoimide (NMI) derivative, M3, in ameliorating multifaceted AD toxicity.

Main Methods:

• Rational design integrating pharmacophores for metal chelation, antioxidant, anti-inflammatory, and Aβ42 aggregation modulation.
• In vitro and cellular assays to assess M3's effects on amyloid toxicity, ROS scavenging, oxidative stress, mitochondrial function, and apoptosis.
• Biological atomic force microscopy and Western blot analysis to evaluate neuroinflammation and pathway inhibition.

Main Results:

• M3 synergistically modulated metal-dependent and -independent amyloid toxicity.
• M3 scavenged reactive oxygen species (ROS), alleviated oxidative stress, and activated Nrf2-mediated stress response.
• M3 protected mitochondria, reduced apoptosis, suppressed microglial activation, and inhibited the NF-κβ pathway, reducing neuroinflammation.

Conclusions:

• The multifunctional NMI derivative M3 demonstrates significant therapeutic potential for Alzheimer's disease.
• The synergistic action of M3 validates the design strategy of integrating multiple pharmacophores to combat multifactorial AD toxicity.